NASDAQ : RLMD

Relmada Therapeutics, Inc.

$5.46 USD

-$0.75 (-12.08%)

Volume
1.87M
Average Volume
1.61M
Market Capitalization
$572.7M
P/E Ratio
-5.01
Dividend Yield
0.00%
Price Target
$10.00
Year High
$8.00
Year Low
$0.55
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$18.26
Analyst Rating

Sell

2 Rating Score

UPSIDE/DOWNSIDE

-45.4% DOWNSIDE

$10.00 Price Target

UPSIDE/DOWNSIDE HIGH

-54.5% DOWNSIDE

$12.00 Price Target High

UPSIDE/DOWNSIDE LOW

-31.8% DOWNSIDE

$8.00 Price Target Low

RLMD Upgrades Downgrades Consensus

Overall Consensus: Buy  |  Total Analysts: 8

Strong Buy Buy Hold Sell Strong Sell
0 5 2 1 0
Analyst Company Analyst Name Price Target Price When Posted Date Upside/Downside
Mizuho Securities Uy Ear $10 $5.91 2026-03-13 02:49 PM 69.2%
Goldman Sachs Andrea Tan $2 $2.95 2024-06-04 11:55 PM -32.2%
Jefferies Andrew Tsai $8 $6.475 2022-10-13 11:47 AM 23.6%
Oppenheimer Jay Olson $7 $6.7483 2022-10-13 07:55 AM 3.7%